Compare ORRF & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORRF | FTRE |
|---|---|---|
| Founded | 1919 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 737.4M | 864.4M |
| IPO Year | N/A | N/A |
| Metric | ORRF | FTRE |
|---|---|---|
| Price | $37.94 | $15.67 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 8 |
| Target Price | ★ $42.00 | $11.36 |
| AVG Volume (30 Days) | 291.8K | ★ 1.4M |
| Earning Date | 01-30-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.86% | N/A |
| EPS Growth | ★ 198.98 | N/A |
| EPS | ★ 3.78 | N/A |
| Revenue | $247,296,000.00 | ★ $2,759,900,000.00 |
| Revenue This Year | $26.82 | $3.17 |
| Revenue Next Year | $2.18 | $0.04 |
| P/E Ratio | $10.00 | ★ N/A |
| Revenue Growth | ★ 66.90 | 1.88 |
| 52 Week Low | $25.57 | $3.97 |
| 52 Week High | $39.39 | $20.86 |
| Indicator | ORRF | FTRE |
|---|---|---|
| Relative Strength Index (RSI) | 71.37 | 72.27 |
| Support Level | $37.63 | $15.43 |
| Resistance Level | $38.38 | $16.94 |
| Average True Range (ATR) | 0.63 | 1.06 |
| MACD | 0.15 | 0.23 |
| Stochastic Oscillator | 85.36 | 73.77 |
Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.